NA

Nuode Asset Management

Asia, Shanghai, China, Shanghai

Description

Nuode Asset Management is a fund management company based in China.

Investor Profile

Nuode Asset Management has backed more than 7 startups, with 5 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Manufacturing, Medical, Pharmaceutical.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • China (100%)

Industry Focus

  • Manufacturing
  • Medical
  • Pharmaceutical
  • Enterprise
  • Aerospace
  • Industrial
  • Industrial Manufacturing
  • Furniture
  • Chemical
  • Electronics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nuode Asset Management frequently co-invest with?

China Asset Management
Asia, Beijing, China, Beijing
Co-Investments: 3
Goldman Sachs
North America, New York, United States, New York
Co-Investments: 1
Cinda Securities
Asia, Beijing, China, Beijing
Co-Investments: 1
Caitong Fund Management Co.
Asia, Shanghai, China, Shanghai
Co-Investments: 5
GF Securities
Asia, Guangdong, China, Guangzhou
Co-Investments: 2
Guotai Junan Securities
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Huaan Securities
Asia, Anhui, China, Hefei
Co-Investments: 2
China Merchants Bank
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
UBS
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
Huatai Insurance Group
Asia, Beijing, China, Beijing
Co-Investments: 3

Which angels does Nuode Asset Management often collaborate with?

Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Nuode Asset Management?

Shengda Bio-Pharm

Taizhou, Jiangsu, China

Shengda Biopharmaceutical offers the production and sale of food and feed additives.

MedicalPharmaceutical
Post Ipo EquityJun 17, 2025
Amount Raised: $36,403,852
Dizal Pharma

Shanghai, Shanghai, China

Dizal Pharma is a research-based biotechnology company.

BiotechnologyPharmaceutical
Post Ipo EquityApr 17, 2025
Amount Raised: $246,169,029
Sanyou Medical

Shanghai, Shanghai, China

Sanyou Medical is a corporation that is therapy innovation oriented and devotes to the R&D.

Innovation ManagementMedicalMedical DeviceTherapeutics
Post Ipo EquityMar 13, 2025
Amount Raised: $29,566,791
Guangdong Guanghua Sci-tech

Shantou, Guangdong, China

GHTECH is a chemical service provider.

ChemicalElectronicsManufacturing
Post Ipo EquityNov 25, 2024
Amount Raised: $94,952,213
AVICOPTER PLC

Harbin, Heilongjiang, China

AVIC Helicopter designs, develops, manufactures, and sells helicopters, airplane parts, and aviation-related products.

AerospaceIndustrialIndustrial Manufacturing
Post Ipo EquityJul 25, 2024
Amount Raised: $415,633,352
Qumei Home Furnishing Group

Beijing, Beijing, China

QuMei Home Furnishings Group designs, manufactures, and markets furniture products in China.

FurnitureManufacturing
Post Ipo EquityJan 10, 2024
Amount Raised: $76,038,719
DFD

Jiaozuo, Henan, China

DFD is a high-tech enterprise engaged in the research, development, production and sales of high-performance inorganic fluorides.

EnterpriseManufacturing
Post Ipo EquityAug 17, 2023
Amount Raised: $274,672,453

Find More Investors Like Nuode Asset Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Nuode Asset Management | Pipeseed